Stroke therapy

Sci Am. 1991 Jul;265(1):56-63. doi: 10.1038/scientificamerican0791-56.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Animals
  • Arterial Occlusive Diseases / complications
  • Arterial Occlusive Diseases / therapy
  • Calcium / metabolism
  • Cell Survival
  • Cerebral Arterial Diseases / complications
  • Cerebral Arterial Diseases / therapy
  • Cerebrovascular Disorders / etiology
  • Cerebrovascular Disorders / physiopathology
  • Cerebrovascular Disorders / therapy*
  • Dizocilpine Maleate / therapeutic use
  • Excitatory Amino Acid Antagonists
  • Glutamates / metabolism
  • Glutamic Acid
  • Humans
  • Intracranial Embolism and Thrombosis / complications
  • Intracranial Embolism and Thrombosis / therapy
  • Neurons / physiology
  • Pipecolic Acids / therapeutic use
  • Receptors, N-Methyl-D-Aspartate / antagonists & inhibitors
  • Receptors, N-Methyl-D-Aspartate / physiology
  • Tissue Plasminogen Activator / therapeutic use
  • Tomography, Emission-Computed

Substances

  • Excitatory Amino Acid Antagonists
  • Glutamates
  • Pipecolic Acids
  • Receptors, N-Methyl-D-Aspartate
  • Glutamic Acid
  • selfotel
  • Dizocilpine Maleate
  • Tissue Plasminogen Activator
  • Calcium